Khalid Muhammad
- Immunology top 5%
- T-cell and B-cell Immunology 12
- Immune Cell Function and Interaction 7
- Immunotherapy and Immune Responses 5
- Dermatology top 2%
- Biological Psychiatry top 10%
- Rheumatology top 5%
- Biomaterials top 10%
-
- Monoclonal and Polyclonal Antibodies Research 9
-
- Signaling Pathways in Disease 9
- vaccines and immunoinformatics approaches 5
-
- SARS-CoV-2 and COVID-19 Research 5
- COVID-19 Clinical Research Studies 5
- Co-authors
- Yasir WaheedShiza MalikEdgar SerflingAndreas KerstanMatthias GoebelerPetra RollThomas DörnerHelal F. Hetta
- Partner nations
- United Arab EmiratesPakistanGermany
In The Last Decade
Khalid Muhammad
73 papers receiving 2.0k citations
Hit Papers
Peers
Comparison fields: 5 of 166
- Immunology 540
- Dermatology 191
- Biological Psychiatry 50
- Rheumatology 167
- Biomaterials 133
Countries citing papers authored by Khalid Muhammad
This map shows the geographic impact of Khalid Muhammad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Khalid Muhammad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Khalid Muhammad more than expected).
Fields of papers citing papers by Khalid Muhammad
This network shows the impact of papers produced by Khalid Muhammad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Khalid Muhammad. The network helps show where Khalid Muhammad may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Khalid Muhammad, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 4 | |
| 2 | 2025 | 2 | |
| 3 | 2024 | 5 | |
| 4 | 2023 | 1 | |
| 5 | 2023 | 14 | |
| 6 | 2023 | 43 | |
| 7 | Nanotechnology: A Revolution in Modern Industrybreakdown → | 2023 | 499 |
| 8 | 2023 | 19 | |
| 9 | 2022 | 6 | |
| 10 | 2021 | 10 | |
| 11 | 2021 | 59 | |
| 12 | 2021 | 7 | |
| 13 | 2020 | 60 | |
| 14 | 2020 | 14 | |
| 15 | Isolation and molecular characterization of Pasteurella multocida from commercial layer flocks suffering from respiratory syndromes. | 2016 | 2 |
| 16 | Studies on the antibiotic sensitivity pattern of isolates of P. multocida from buffaloes. | 2014 | 1 |
| 17 | OPTIMIZATION OF PHYSICO-CHEMICAL FACTORS AUGMENTING IN VITRO BIOMASS PRODUCTION OF PASTEURELLA MULTOCIDA | 2013 | 3 |
| 18 | Antimicrobial activity of mentofin and its effect on antibody response of broilers to Newcastle Disease virus vaccine. | 2013 | 11 |
| 19 | 2011 | 78 | |
| 20 | STANDARDIZATION OF INDIRECT HAEMAGGLUriON TEST FOR MONITORING PASTEURELLA MULTOCIDA ANTIBODIES | 1998 | 1 |
About Khalid Muhammad
Khalid Muhammad is a scholar working on Immunology, Virology and Biological Psychiatry, having authored 76 papers that have together received 2.1k indexed citations. Recurring topics across this work include T-cell and B-cell Immunology (12 papers), Monoclonal and Polyclonal Antibodies Research (9 papers), Signaling Pathways in Disease (9 papers), Immune Cell Function and Interaction (7 papers), SARS-CoV-2 and COVID-19 Research (5 papers), COVID-19 Clinical Research Studies (5 papers), vaccines and immunoinformatics approaches (5 papers) and Immunotherapy and Immune Responses (5 papers). The work is most often cited by research in Immunology (540 citations), Dermatology (191 citations) and Biological Psychiatry (50 citations). Khalid Muhammad has collaborated with scholars based in United Arab Emirates, Pakistan and Germany. Frequent co-authors include Yasir Waheed, Shiza Malik, Edgar Serfling, Andreas Kerstan, Matthias Goebeler, Petra Roll, Thomas Dörner, Helal F. Hetta, Hans‐Peter Tony and Hermann Einsele. Their work appears in journals such as Vaccines, Frontiers in Immunology, Molecules, Scientific Reports and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.